The Safety of Melasma Treatment in Vitiligo Patients: An International E-Delphi Study. (PubMed, Pigment Cell Melanoma Res) - Oct 21, 2026 - "Topical calcineurin inhibitors, ruxolitinib, tretinoin, corticosteroids, and oral tranexamic acid can be used...This consensus gives clinicians an expert-informed pathway through a common but understudied comorbidity. It also identifies a clear research gap: controlled, mechanistic comparisons of hydroquinone against newer tyrosinase inhibitors specifically in vitiligo-prone skin are still lacking."
Journal • Aesthetic Medicine • Dermatology • Dermatopathology • Immunology • Vitiligo • Tyrosinase
|
|
Albert Wolkerstorfer; Andrea Tovar-Garza; Caio Cesar Silva de Castro; Davinder Parsad; Hyun Jeong Ju; Iltefat H Hamzavi; Julien Seneschal; Jung Min Bae; Khaled Ezzedine; Laila Benzekri; Mahy El-Bassiouny; Marwa Abdallah; Michelle Rodrigues; Nada Elbuluk; Nanja van Geel; Noufal Raboobee; Prasad Kumarasinghe; Samia Esmat; Steven Thng; Tasneem F Mohammad; Thierry Passeron; Viktoria Eleftheriadou
|